Literature DB >> 9474071

Prediction of relapse within eight weeks after an acute asthma exacerbation in adults.

M McCarren1, M F McDermott, R J Zalenski, B Jovanovic, D Marder, D G Murphy, L M Kampe, V M Misiewicz, R J Rydman.   

Abstract

Associations between historical, presenting, and treatment-related characteristics and relapse within 8 weeks after a moderate to severe asthma exacerbation were studied in a cohort of 284 adult asthmatics. Data were collected prospectively, and a multivariate model was developed and internally validated. Within 10 days, only 8% had relapsed, increasing to 45% by 8 weeks. Three variables that could be identified at the time of discharge were independently associated with relapse. These included: having made three or more visits to an emergency department in the prior 6 months (hazard ratio (HR) = 2.3, 95% CI = 1.6-3.4); difficulty performing work or activities as a result of physical health in the 4 weeks prior (HR = 2.7, 95% CI = 1.6-4.3); discontinuing hospital-based treatment for the exacerbation within 24 hours without having achieved a peak expiratory flow rate of at least 50% of predicted (HR = 2.6, 95% CI = 1.6-4.1). These risk factors may help to identify patients with poorly controlled asthma in need of more intensive and comprehensive management.

Entities:  

Mesh:

Year:  1998        PMID: 9474071     DOI: 10.1016/s0895-4356(97)00246-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

Review 1.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.

Authors:  Urs Frey; Béla Suki
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Tailored education may reduce health literacy disparities in asthma self-management.

Authors:  Michael K Paasche-Orlow; Kristin A Riekert; Andrew Bilderback; Arjun Chanmugam; Peter Hill; Cynthia S Rand; Fred L Brancati; Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2005-08-04       Impact factor: 21.405

Review 3.  Discharge of the asthmatic patient.

Authors:  B A Markoff; J F MacMillan; V Kumra
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

4.  Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations.

Authors:  Rose Du; Augusto A Litonjua; Kelan G Tantisira; Jessica Lasky-Su; Shamil R Sunyaev; Barbara J Klanderman; Juan C Celedón; Lydiana Avila; Manuel E Soto-Quiros; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2011-11-01       Impact factor: 10.793

5.  Characteristics of asthmatic patients with and without repeat emergency department visits at an inner city hospital.

Authors:  Sucheta Pai; Carol A Mancuso; Raghu Loganathan; Carla Boutin-Foster; Riyad Basir; Balavenkatesh Kanna
Journal:  J Asthma       Date:  2014-03-27       Impact factor: 2.515

Review 6.  Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.

Authors:  Douglas W Mapel; Melissa H Roberts
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

7.  Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review.

Authors:  Jesse Hill; Nicholas Arrotta; Cristina Villa-Roel; Liz Dennett; Brian H Rowe
Journal:  BMJ Open Respir Res       Date:  2017-01-27

8.  A systematic review of methodology used in the development of prediction models for future asthma exacerbation.

Authors:  Joshua Bridge; John D Blakey; Laura J Bonnett
Journal:  BMC Med Res Methodol       Date:  2020-02-05       Impact factor: 4.615

9.  Small Airway Dysfunction in Cough Variant Asthma: Prevalence, Clinical, and Pathophysiological Features.

Authors:  Fang Yi; Ziyu Jiang; Hu Li; Chunxing Guo; Hankun Lu; Wei Luo; Qiaoli Chen; Kefang Lai
Journal:  Front Physiol       Date:  2022-01-13       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.